- Home
- LUCD vs PIM Comparison
LUCD vs PIM Comparison
Compare LUCD & PIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LUCD | PIM |
|---|---|---|
| Founded | 2018 | 1988 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 190.8M | 159.5M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | LUCD | PIM |
|---|---|---|
| Price | $1.16 | $3.26 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $4.13 | N/A |
| AVG Volume (30 Days) | ★ 486.8K | 113.7K |
| Earning Date | 05-13-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 8.28% |
| EPS Growth | ★ 16.67 | N/A |
| EPS | N/A | ★ 0.05 |
| Revenue | ★ $4,346,000.00 | N/A |
| Revenue This Year | $126.14 | N/A |
| Revenue Next Year | $138.77 | N/A |
| P/E Ratio | ★ N/A | $65.20 |
| Revenue Growth | ★ 79.00 | N/A |
| 52 Week Low | $0.95 | $3.14 |
| 52 Week High | $1.70 | $3.50 |
Technical Indicators
Market Signals| Indicator | LUCD | PIM |
|---|---|---|
| Relative Strength Index (RSI) | 36.47 | 54.67 |
| Support Level | $1.01 | $3.14 |
| Resistance Level | $1.22 | $3.37 |
| Average True Range (ATR) | 0.06 | 0.05 |
| MACD | -0.00 | 0.01 |
| Stochastic Oscillator | 31.25 | 71.43 |
Price Performance
Historical ComparisonAbout LUCD Lucid Diagnostics Inc.
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.
About PIM Putnam Master Intermediate Income Trust
Putnam Master Intermediate Income Trust is a closed-end fund. Its investment objective is to provide high current income and relative stability of net asset value. The fund pursues its goal by investing in U.S. high-grade, high-yield, and international fixed-income securities with limited maturities. The fund's portfolio includes the United States Government and agency mortgage obligations; mortgage-backed securities; corporate bonds and notes, and foreign government and agency bonds and notes.